Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Frequency Therapeutics Inc
KRROCurrent price
49.7 USD
-4.31 USD (-7.98%)
Last closed
55.01 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
654 636 928 USD
Yield for 12 month
+14.49 %
1Y
3Y
5Y
10Y
15Y
KRRO
Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases primarily in the United States. Its lead product candidate is KRRO-110 which is in preclinical trials for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, OPERA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe alcohol-associated hepatitis, and other subsets of pain. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts. Address: One Kendall Square, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
134.6 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 630 000 USD
Last Year
-2 511 000 USD
Current Quarter
-721 000 USD
Last Quarter
-726 000 USD
Key Figures KRRO
1 year
3 years
5 years
10 years
EBITDA
-88 268 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-31.91 %
PEG Ratio
–
Return On Equity TTM
-62.72 %
Wall Street Target Price
134.6 USD
Revenue TTM
–
Book Value
21.35 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-9.19 USD
Diluted Eps TTM
-9.19 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics KRRO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History KRRO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
06.11.2023
Dividend Date
–
Stock Valuation KRRO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-5.6031
Price Book MRQ
3.305
Financials KRRO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KRRO
For 52 weeks
30.01 USD
98 USD
50 Day MA
48.59 USD
Shares Short Prior Month
222 784
200 Day MA
51.6 USD
Short Ratio
3.91
Shares Short
274 235
Short Percent
3.89 %
BeatStart